SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-054980
Filing Date
2020-10-15
Accepted
2020-10-15 20:11:54
Documents
2
Period of Report
2020-10-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5400
2 EX-24 DOCUMENT attachment1.htm EX-24 3734
  Complete submission text file 0001209191-20-054980.txt   10485
Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Issuer) CIK: 0001819790 (see all company filings)

IRS No.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 15440 LAGUNA CANYON ROAD, SUITE 160 IRVINE CA 92618
Business Address
Neervannan Seshadri (Reporting) CIK: 0001827584 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39614 | Film No.: 201242512